Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)

NCT05971693 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT05971693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05971693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 12, 2023
Completion date
September 5, 2025
Enrollment
188 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation